Jacobi Capital Management’s Integra LifeSciences IART Stock Holding History

Jacobi Capital Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-400	Closed	-$27K	–	811
2021 Q3	$27K	Hold	400	–	–	﹤0.01%	789
2021 Q2	$27K	Hold	400	–	–	﹤0.01%	764
2021 Q1	$28K	Hold	400	–	–	﹤0.01%	711
2020 Q4	$26K	Hold	400	–	–	﹤0.01%	670
2020 Q3	$19K	Hold	400	–	–	﹤0.01%	681
2020 Q2	$19K	Hold	400	–	–	﹤0.01%	657
2020 Q1	$18K	Hold	400	–	–	﹤0.01%	596
2019 Q4	$23K	Hold	400	–	–	﹤0.01%	601
2019 Q3	$24K	Hold	400	–	–	﹤0.01%	570
2019 Q2	$22K	Buy	+400	New	+$20.6K	﹤0.01%	588

Other funds holding IART

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

EVM

Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Jacobi Capital Management's IART Position: Q4 2021 in Review

Jacobi Capital Management sold out of Integra LifeSciences (IART) in Q4 2021, closing a stake of 400 shares — an estimated $27K sold.

Jacobi Capital Management first reported a position in IART in Q2 2019 and held it in 10 quarters. The position peaked at $28K in Q1 2021. 277 funds tracked by Wall St. Rank hold IART as of Q4 2021.

Jacobi Capital Management reported no remaining Integra LifeSciences position as of Q4 2021 after selling out during the quarter.
Jacobi Capital Management sold 400 Integra LifeSciences shares in Q4 2021, an estimated $27K.
Jacobi Capital Management first reported a position in Integra LifeSciences in Q2 2019 and held it in 10 quarters.
Jacobi Capital Management's Integra LifeSciences position peaked at $28K in Q1 2021.
277 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2021.

Based on Jacobi Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.